The effects of clobetasol propionate spray, 0.05% versus vehicle spray on the signs of plague psoriasis on the body and scalp

被引：0

作者：

Jarratt, Michael ^{[1
]}

Sofen, Howard L. ^{[2
]}

Caveney, Scott W. ^{[3
]}

机构：

[1] DermResearch Inc, Austin, TX USA

[2] Dermatol Res Associates, Los Angeles, CA USA

[3] Galderma Labs LP, Ft Worth, TX USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2012年 / 66卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：AB204 / AB204

页数：1

共 50 条

[41] Once-daily clobetasol propionate 0.05% shampoo for scalp psoriasis improves quality of life and achieves high patient satisfaction levels
Tan, Jerry
Wang, Beatrice
Gratton, David
Thomas, Richard
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB133 - AB133
[42] Safety assessment of clobetasol propionate 0.05% shampoo: Hypothalamic-pituitary-adrenail axis suppression, atrophogenicity, and ocular safety in subjects with psoriasis of the scalp
Andres, P
Poncet, M
Sidou, F
Soto, P
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P195 - P195
[43] Topical clobetasol propionate spray is effective for the treatment of patients with moderate to severe plaque psoriasis already on a stable, ongoing treatment regimen
Feldman, Steven
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB133 - AB133
[44] Safety and efficacy of two regimens involving clobetasol spray, 0.05% and calcitriol ointment, 3 μg/g for moderate plaque psoriasis
Brodell, Robert
Goffe, Bernard S.
Weiss, Jonathan S.
Bruce, Suzanne
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB149 - AB149
[45] The Use of a Reliable, Ubiquitous, Inexpensive, and User-Friendly Tablet-Based System to Track Target Lesion Improvements in Subjects With Plaque Psoriasis Treated With Clobetasol Propionate 0.05% Spray
Wiser, Thomas H.
Meckfessel, Matthew H.
Winkelman, Warren
JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (03) : 236 - 241
[46] An Open-label, Multicenter Study of the Efficacy and Safety of a Weekday/Weekend Treatment Regimen With Calcitriol Ointment 3 μg/g and Clobetasol Propionate Spray 0.05% in the Management of Plaque Psoriasis
Hudson, Charles P.
Kempers, Steven
Menter, Alan
Papp, Kim
Smith, Stacy
Sofen, Howard
Colon, Luz E.
Johnson, Lori A.
Gottschalk, Ronald
CUTIS, 2011, 88 (04): : 201 - 207
[47] An Open-Label, Multicenter Study of the Efficacy and Safety of an AM/PM Treatment Regimen With Clobetasol Propionate Spray 0.05% and Calcitriol Ointment 3 μg/g in the Management of Plaque Psoriasis
Menter, Alan
Sofen, Howard
Smith, Stacy
Papp, Kim
Kempers, Steven
Hudson, Charles P.
Colon, Luz E.
Johnson, Lori A.
Gottschalk, Ronald
CUTIS, 2011, 88 (01): : 46 - 51
[48] Quality of life results from a large community-based trial assessing clobetasol propionate 0.05% spray as monotherapy and add-on therapy
Koo, John
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB187 - AB187
[49] COMPARATIVE-STUDIES OF AUGMENTED BETAMETHASONE DIPROPIONATE LOTION 0.05-PERCENT AND CLOBETASOL PROPIONATE SOLUTION 0.05-PERCENT - CORRELATION OF THE VASOCONSTRICTION ASSAY AND CLINICAL ACTIVITY IN SCALP PSORIASIS
JARRATT, M
DAVIS, JG
GILTNER, MP
JONES, ML
PEETS, EA
ADVANCES IN THERAPY, 1991, 8 (02) : 103 - 111
[50] The evaluation of morning cortisolaemia in patients treated with short-contact 0.05% clobetasol propionate shampoo once daily during 4 weeks therapy for scalp psoriasis
Kwiek, B.
Rajchel, A.
Langner, A.
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1416 - 1416

← 1 2 3 4 5 →